OTCM
LOVFF
Market cap151mUSD
Oct 07, Last price
1.51USD
1D
-1.27%
1Q
15.31%
IPO
742.91%
Name
Cannara Biotech Inc
Chart & performance
P/E
16.26
P/S
1.98
EPS
0.13
Div yield, %
—
Shrs. gr., 5y
5.30%
Rev. gr., 5y
111.25%
Revenues
107m
+31.28%
Net income
13m
+103.09%
CFO
20m
+87.34%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Cannara Biotech Inc., alongside its affiliated entities, specializes in the indoor cultivation, processing, and distribution of cannabis and related products across Canada. The company operates with a dual business model, encompassing both cannabis operations and real estate activities. Its diverse product portfolio is marketed under distinct brand names such as TRIBAL, nugz, and ORCHID CBD. Distribution is managed through both wholesale channels and online retail platforms. Established in 2017, Cannara Biotech Inc. maintains its headquarters in Saint-Laurent, Canada.
Key people
Zohar Krivorot
President, Chief Executive Officer, Director · since 2018
Lennie Ryer
Chief Financial Officer · since 2018
Besar Xhelili
Director · since 2018
Thomas Faifull
Independent Director · since 2018
Independent Director · since 2018
Headquarters & legal address
1055 West Georgia St.
Vancouver, BC V6E 4N7
CA
Vancouver, BC V6E 4N7
CA
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2025‑08 | 2024‑08 | 2023‑08 | 2022‑08 | 2021‑08 | 2020‑08 | 2019‑08 | 2018‑08 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||